Abrogation of KLF5 sensitizes &amp;lt;italic&amp;gt;BRCA1&amp;lt;/italic&amp;gt;-proficient                     pancreatic cancer to PARP inhibition

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.3724/abbs.2023288

Abrogation of KLF5 sensitizes &lt;italic&gt;BRCA1&lt;/italic&gt;-proficient pancreatic cancer to PARP inhibition

Zheng Zhang & Liang Liu et al.

Poly ADP-ribose polymerase (PARP) inhibitor monotherapies are selectively effective in patients with pancreatic, breast, prostate, and ovarian cancers with

Links

DOI PubMed

Journal

Acta Biochimica et Biophysica Sinica

Authors

Zheng Zhang, Yuxin Liu, Yaolin Xu, Zijin Xu, Jinbin Jia, Yun Jin, Wenquan Wang, Liang Liu

Abrogation of KLF5 sensitizes &amp;lt;italic&amp;gt;BRCA1&amp;lt;/italic&amp;gt;-proficient pancreatic cancer to PARP inhibition

Links

Journal

Authors

Abrogation of KLF5 sensitizes <italic>BRCA1</italic>-proficient pancreatic cancer to PARP inhibition